Anti-CTLA-4 (CD 152) monoclonal antibody-induced autoimmune interstitial nephritis

Por Jolly, Elaine C., Clatworthy, Menna R., Lawrence, Christopher, Nathan, Paul D., Farrington, Ken
Publicado no NDT Plus (2009)

Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in...

Por Carvajal, Richard D., Schwartz, Gary K., Mann, Helen, Smith, Ian, Nathan, Paul D.
Publicado no BMC Cancer (2015)

Metastatic disease from uveal melanoma: treatment options and future prospects

Por Carvajal, Richard D, Schwartz, Gary K, Tezel, Tongalp, Marr, Brian, Francis, Jasmine H, Nathan, Paul D
Publicado no Br J Ophthalmol (2017)

Phase I Study of Nintedanib Incorporating Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Advanced Solid Tumors

Por Lee, Chooi Peng, Taylor, N. Jane, Attard, Gerhardt, Pacey, Simon, Nathan, Paul D., de Bono, Johann S., Temple, Graham, Bell, Susan, Stefanic, Martin, Stopfer, Peter, Tang, Adrian, Koh, Dow-Mu, Collins, David J., d’Arcy, James, Padhani, Anwar R., Leach, Martin O., Judson, Ian R., Rustin, Gordon J.
Publicado no Oncologist (2015)

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Por Ribas, Antoni, Kefford, Richard, Marshall, Margaret A., Punt, Cornelis J.A., Haanen, John B., Marmol, Maribel, Garbe, Claus, Gogas, Helen, Schachter, Jacob, Linette, Gerald, Lorigan, Paul, Kendra, Kari L., Maio, Michele, Trefzer, Uwe, Smylie, Michael, McArthur, Grant A., Dreno, Brigitte, Nathan, Paul D., Mackiewicz, Jacek, Kirkwood, John M., Gomez-Navarro, Jesus, Huang, Bo, Pavlov, Dmitri, Hauschild, Axel
Publicado no J Clin Oncol (2013)